Gilenya (fingolimod), first MS oral drug, will be available in US with financial help from Novartis - Multiple Sclerosis
Links shared publicly online about this topic.
- 823total visits
Gilenya (fingolimod), first MS oral drug, will be available in US with financial help from Novartis - Multiple Sclerosis
Even before I was diagnosed with MS in 2005, I researched the different treatment options. I learned about the ABC’s (Avonex, Betaseron, Copaxone),...
View full resource at healthcentral.com
Tags: Multiple Sclerosis, Multiple Sclerosis Medication, Drug, Copaxone, Avonex, Betaseron, Novartis
Most Recently Shared on October 6, 2010 at 2:22 pm By:
RT @LisaEmrich Gilenya (fingolimod), first MS oral drug, will be available in US with financial help from Novartis http://ow.ly/19iRvv
Advertisement
